RNase inhibitor (Recombinant) CAS UENA-0193
RNase inhibitor (Recombinant)
Definition of active unit
Definition of active unit: 1 active unit is defined as the amount of enzyme needed to inhibit 50% of RNase A activity (RNase A activity is determined by inhibiting its hydrolysis of cytidine 2′ and 3′-cyclic monophosphate.).
NONH for all modes of transport
Specifications and Other Information of Our RNase inhibitor (Recombinant) CAS UENA-0193
This product is the murine RNase inhibitor recombinantly expressed in E. coli. It binds to RNase to form a complex, thereby inhibiting RNase activity and protecting target RNA from degradation.
Efficient inhibition of the activity of RNase A, RNase B and RNase C, no nuclease contamination, no residual microbial-derived DNA. Improving the yield of all RNA experiment products and the mRNA integrity of IVT products. Suitable for almost all experiments sensitive to RNA integrity.
|Item No.||Composition||Storage Temperature|
|I||RNase Inhibitor (Recombinant) (40 U/μL)||-20||0.5mL||5mL|
Purity ≥ 95%, residual host cell DNA ≤ 100pg/mg, residual host cell protein ≤ 50ppm, residual endotoxin ≤10EU/mg, no residual RNase, endonuclease, exonuclease or protease, germ-free, pathogen-free.
This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).